Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.

Adamo CM, Dai DF, Percival JM, Minami E, Willis MS, Patrucco E, Froehner SC, Beavo JA.

Proc Natl Acad Sci U S A. 2010 Nov 2;107(44):19079-83. doi: 10.1073/pnas.1013077107. Epub 2010 Oct 18.

2.

Proteomic profiling of the dystrophin-deficient mdx phenocopy of dystrophinopathy-associated cardiomyopathy.

Holland A, Ohlendieck K.

Biomed Res Int. 2014;2014:246195. doi: 10.1155/2014/246195. Epub 2014 Mar 20. Review.

3.

Brain function in Duchenne muscular dystrophy.

Anderson JL, Head SI, Rae C, Morley JW.

Brain. 2002 Jan;125(Pt 1):4-13. Review.

4.

What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?

Manning J, O'Malley D.

J Muscle Res Cell Motil. 2015 Apr;36(2):155-67. doi: 10.1007/s10974-015-9406-4. Epub 2015 Feb 11. Review.

PMID:
25669899
5.

Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system.

Sabharwal R, Chapleau MW.

Exp Physiol. 2014 Apr;99(4):627-31. doi: 10.1113/expphysiol.2013.074336. Epub 2013 Dec 13. Review.

6.

The value of mammalian models for duchenne muscular dystrophy in developing therapeutic strategies.

Banks GB, Chamberlain JS.

Curr Top Dev Biol. 2008;84:431-53. doi: 10.1016/S0070-2153(08)00609-1. Review.

PMID:
19186250
7.

Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Kornegay JN, Spurney CF, Nghiem PP, Brinkmeyer-Langford CL, Hoffman EP, Nagaraju K.

ILAR J. 2014;55(1):119-49. doi: 10.1093/ilar/ilu011. Review.

8.

What do animal models have to tell us regarding Duchenne muscular dystrophy?

Wells DJ, Wells KE.

Acta Myol. 2005 Dec;24(3):172-80. Review.

PMID:
16629050
9.

Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Kornegay JN, Bogan JR, Bogan DJ, Childers MK, Li J, Nghiem P, Detwiler DA, Larsen CA, Grange RW, Bhavaraju-Sanka RK, Tou S, Keene BP, Howard JF Jr, Wang J, Fan Z, Schatzberg SJ, Styner MA, Flanigan KM, Xiao X, Hoffman EP.

Mamm Genome. 2012 Feb;23(1-2):85-108. doi: 10.1007/s00335-011-9382-y. Epub 2012 Jan 5. Review.

10.

Gene transfer studies in animals: what do they really tell us about the prospects for gene therapy in DMD?

Wells DJ, Wells KE.

Neuromuscul Disord. 2002 Oct;12 Suppl 1:S11-22. Review.

PMID:
12206790
11.

The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy.

Kuno A, Tanno M, Horio Y.

Ann N Y Acad Sci. 2015 Aug;1348(1):46-54. doi: 10.1111/nyas.12812. Epub 2015 Jun 24. Review.

PMID:
26109180
12.

Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy.

McGreevy JW, Hakim CH, McIntosh MA, Duan D.

Dis Model Mech. 2015 Mar;8(3):195-213. doi: 10.1242/dmm.018424. Review.

13.

Duchenne muscular dystrophy: a cerebellar disorder?

Cyrulnik SE, Hinton VJ.

Neurosci Biobehav Rev. 2008;32(3):486-96. Epub 2007 Oct 4. Review.

PMID:
18022230
14.

X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.

Nakamura A.

Pharmaceuticals (Basel). 2015 Jun 9;8(2):303-20. doi: 10.3390/ph8020303. Review.

15.

PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer.

Das A, Durrant D, Salloum FN, Xi L, Kukreja RC.

Pharmacol Ther. 2015 Mar;147:12-21. doi: 10.1016/j.pharmthera.2014.10.003. Epub 2014 Oct 31. Review.

16.

Acetylcholine, GABA and neuronal networks: a working hypothesis for compensations in the dystrophic brain.

Cohen EJ, Quarta E, Fulgenzi G, Minciacchi D.

Brain Res Bull. 2015 Jan;110:1-13. doi: 10.1016/j.brainresbull.2014.10.004. Epub 2014 Oct 16. Review.

PMID:
25445612
17.

Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil.

Zhang H, Wang X.

Future Cardiol. 2015 Mar;11(2):177-89. doi: 10.2217/fca.15.3. Review.

18.

Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies.

Anand A, Tyagi R, Mohanty M, Goyal M, Silva KR, Wijekoon N.

Ann Neurosci. 2015 Apr;22(2):108-18. doi: 10.5214/ans.0972.7531.221210. Review.

Items per page

Supplemental Content

Write to the Help Desk